Poor bone matrix quality: What can be done about it?

Area of Science:

• Biomaterials Science
• Skeletal Biology
• Orthopedics

Background:

• Bone's mechanical integrity relies on its hierarchical composite structure, extracellular matrix, remodeling, and microdamage dynamics.
• Aging and disease impair biological regulators, leading to defective bone matrix and increased skeletal fragility.

Purpose of the Study:

• To review the contribution of bone quality to fracture resistance.
• To identify potential therapeutic targets for skeletal fragility in aging and disease.

Main Methods:

• Literature review focusing on bone matrix composition, regulation, and mechanical properties.
• Analysis of biological and mechanical factors influencing bone quality.
• Evaluation of current and emerging therapeutic strategies for skeletal fragility.

Main Results:

• Bone quality is a critical determinant of fracture resistance, influenced by matrix organization and regulatory mechanisms.
• Defects in bone quality due to aging or disease compromise mechanical properties, leading to fragility.
• Current targeted therapies face limitations in tissue selectivity and exhibit adverse side effects.

Conclusions:

• Enhanced understanding of bone quality regulation is essential for developing effective treatments for skeletal fragility.
• Advances in drug delivery and preclinical models are key to translating targeted therapeutics into clinical practice.
• Future research should focus on improving tissue selectivity and reducing side effects of bone-targeting therapies.